Advisory Group | Thanzi la Onse

Dr. Collins Magalasi

Advisory Group Chair
Malawi Energy Regulatory Authority and State House, Malawi

Collins Magalasi is a renowned economist and currently holds the position of Chief Executive Officer for the Malawi Energy Regulatory Authority (MERA). He also serves as Chief Economic Advisor to the President of the Republic of Malawi.

Prof. Sir Ian Weller

Advisory Group Deputy Chair
University College London

Professor Ian Weller is an Emeritus Professor of Sexually Transmitted Diseases at University College London. Chair of the Steering Committees of a number of international trials and studies in HIV/AIDS, funded by the UK’s Medical Research Council, the Wellcome Trust and Department of International Development. He was Vice-Chair of the UK’s Commission on Human Medicines and is Chair of the trustees of the HIV Research Trust providing scholarships for health care professionals from resource limited countries.

Prof. Diana M. Gibb

Medical Research Council Clinical Trials Unit, University College London

Diana is a paediatrician, Professor of Epidemiology and Leader of the Paediatric Research Programme at the MRC Clinical Trials Unit at UCL, London. Since early 1990s, she has coordinated multi-country paediatric HIV trials across Europe, Thailand and South America, expanding to South/East Africa in 1999 and recently to India. Her focus has widened to tuberculosis, malaria and antimicrobial resistance. Evaluating children’s medicines suitable to the setting is a theme across all research and capacity building is a key component of trial programmes.

Dr. Elly Katabira

Makerere University

Elly T Katabira is a Professor of Medicine at the School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.

Dr. Katabira received his medical degree at Makerere University and went on to specialise in Neurology in England. He has been working in the field of HIV as a clinician, an educator and a researcher since 1985. He started the first AIDS clinic in Africa and has worked with many organizations including WHO and UNAIDS. He joined the IAS in 1990 and in 2000 became the regional representative at the governing council. In 2010 he became the President of IAS up to 2012.

Clinical Associate Prof. Carol Levin

University of Washington, Department of Global Health

Carol Levin is an expert in costing health technologies and interventions delivered in public health delivery systems. Currently, she is the director for the Global Health Cost Consortium to strengthen access to, and the use of, high quality cost data for HIV and TB. Previously, she led the systematic review of costs of global health interventions as part of the Disease Control Priorities Project.

Prof. Alistair McGuire

London School of Economics

Professor Alistair McGuire is Chair in Health Economics in the Department of Health Policy.

He has been interested in the economics of health care for over thirty years. Professor McGuire’s research interests cover all topics in health economics, including international comparisons, economics of the hospital, public/private sector interface, cost-effectiveness analysis of health technologies, and health economics alongside clinical trials.

Dr. Charles Mwansambo

Chief of Health Services for Malawi

Dr Charles Mwansambo is a UK trained Paediatrician and is a Fellow of the Royal College of Paediatrics and Child Health. He is currently the Chief of Health Services for Malawi.

Prior to the current post, he was Secretary for Health and before that was a Consultant Paediatrician and Head of Department at the Kamuzu Central Hospital in Malawi’s Capital City, Lilongwe, where he still practices to date. He also served as Hospital Director at the same institution in the late 90’s and early 2000’s.

Dr. McBride Nkhalamba

African Union – Head of Division: Research, Methodology and Development

McBride Mkhalamba is Head of Division for Research, Methodology and Development at the Africa Peer Review Mechanism Continental Secretariat at the African Union. He provides executive leadership and strategic direction in thematic research and country profiling at the inter-governmental agency. He is also responsible for coordinating the integration of research outcomes into country governance self-assessment processes.

Prof. Moffat Nyirenda

London School of Hygiene and Tropical Medicine, and MRC/UVRI & LSHTM Uganda Research Unit

Professor Moffat Nyirenda is a Diabetologist/Endocrinologist and Professor of Medicine (Global Non-Communicable Diseases) at the LSHTM, and lead the chronic non-communicable diseases (NCDs) research theme at MRC/UVRI & LSHTM Uganda Research Unit. Before joining MRC/UVRI & LSHTM Uganda Research Unit, Moffat was Director of Malawi Epidemiology and Intervention Research Unit. Moffat’s research interests lie in mechanistic understanding (clinical and laboratory phenotyping) of the aetiology of NCDs. He serves on a number of committees, including being chairman of Scientific Advisory Board for GSK Africa NCD Open Lab and member of the Wellcome Trust Public Health and Tropical Medicine Interview Committee, among many others.

Dr. John Phuka

School of Public Health, University of Malawi

Dr. John Phuka is currently Dean of the School of Public Health. His research interests are largely in nutritional related matters and interactions. His expertise led him to advising the Malawian Government and its partners through serving in technical working groups and nutrition policy advisory boards.

Prof. Bayard Roberts

London School of Hygiene and Tropical Medicine, and representative of the GCRF RECAP Project

Professor Bayard Roberts is the Director of the Centre for Global Chronic Conditions at LSHTM, and Editor-in-Chief of the BMC journal Conflict and Health.

His research addresses the health determinants, policies and systems of countries experiencing major social change such as those affected by armed conflict and forced migration. This research has focused particularly on chronic conditions of mental health and non-communicable diseases, and harmful health behaviours such as tobacco and harmful alcohol use.